Iovera is a medical technology company specializing in cryotherapy solutions for pain management. The company's flagship product applies freezing cold to peripheral nerve tissue, effectively blocking or relieving pain for up to 90 days. This treatment is particularly beneficial for patients suffering from osteoarthritis knee pain, post-surgical pain from knee replacements, and other conditions affecting the hip, shoulder, foot, ankle, and spine. Iovera's services are FDA-cleared and can be administered in various settings, including hospital outpatient departments, ambulatory surgery centers, and doctors' offices. The company primarily serves healthcare providers and patients seeking non-opioid pain relief solutions. Iovera operates in the medical device market, leveraging a business model that includes direct sales and partnerships with healthcare institutions. Revenue is generated through the sale of its cryotherapy systems and related consumables.

Keywords: cryotherapy, pain management, FDA-cleared, peripheral nerve, osteoarthritis, knee replacement, non-opioid, medical device, healthcare providers, outpatient treatment.